HEXAPHARMATEC CO LTD has a total of 17 patent applications. It decreased the IP activity by 60.0%. Its first patent ever was published in 2016. It filed its patents most often in Republic of Korea, Japan and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are ASCENEURON S A, GPI NIL HOLDINGS and IMPACT THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 7 | |
#2 | Japan | 5 | |
#3 | WIPO (World Intellectual Property Organization) | 2 | |
#4 | Australia | 1 | |
#5 | Canada | 1 | |
#6 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Heterocyclic compounds | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Organic chemistry methods |
# | Name | Total Patents |
---|---|---|
#1 | Han Shin | 17 |
#2 | Lee Shin Young | 6 |
#3 | Jeon Seong Hyeon | 6 |
#4 | Lee Jae-Hyoung | 5 |
#5 | Lee Na Ri | 3 |
#6 | Lee Jae Hyoung | 2 |
#7 | Hong You Hwa | 1 |
#8 | Lee Na-Ri | 1 |
#9 | Lee Gyung Rak | 1 |
#10 | Lee Gyung-Rak | 1 |
Publication | Filing date | Title |
---|---|---|
EP3814340A1 | Novel catechol derivatives or salt thereof, processes for preparing the same, and pharmaceutical compositions comprising the same | |
KR102060318B1 | Novel intermediate, processes for preparing the same, and processes for preparing rosuvastatin calcium salt using the same | |
KR20190046126A | Improved process for preparing acotiamide | |
KR20190016208A | Novel sulfonamide intermediates and processes for preparing silodosin using the same | |
KR20180017672A | Process for purifying 1-(4-amino-2-methylbenzoyl)-7-chloro-5-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine | |
KR20180009228A | Improved process for preparing synthetic intermediates of tolvaptan | |
KR20170106816A | New intermediates of Imidafenacin, the preparation of the same and the preparation of Imidafenacin using the same |